Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.93 USD | +2.73% | +1.16% | -46.79% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 357M |
---|---|---|---|---|---|
Net income 2024 * | -73M | Net income 2025 * | -105M | EV / Sales 2024 * | - |
Net cash position 2024 * | 311M | Net cash position 2025 * | 430M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.67
x | P/E ratio 2025 * |
-3.78
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.39% |
Latest transcript on Tourmaline Bio, Inc.
1 day | +2.73% | ||
1 week | +1.16% | ||
Current month | +1.16% | ||
1 month | -11.67% | ||
3 months | -66.66% | ||
6 months | -25.19% | ||
Current year | -46.79% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +3.81% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 13.93 | +2.73% | 140,700 |
24-06-06 | 13.56 | -2.52% | 111,257 |
24-06-05 | 13.91 | +0.14% | 177,509 |
24-06-04 | 13.89 | +2.51% | 375,319 |
24-06-03 | 13.55 | -1.60% | 225,280 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-46.79% | 357M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+2.13% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- TRML Stock